Evidence map›Paper›PMID 41504493›Full record

ArticleHLA2026

Post-Transplant DSA Monitoring After HLAi Kidney Transplantation: Key Time Points.

Ghofran Hijazi, Sunil Daga, Mason Phillpott, David Briggs, Nithya Krishnan, Rob Higgins, Natalia Khovanova

Abstract read
In one paragraph

Article in HLA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghofran HijaziSchool of Engineering, University of Warwick, Coventry, UK.
Sunil DagaSchool of Engineering, University of Warwick, Coventry, UK.ORCID https://orcid.org/0000-0002-4592-8561
Mason PhillpottSchool of Engineering, University of Warwick, Coventry, UK.
David BriggsHistocompatibility and Immunogenetics Laboratory, NHSBT Birmingham, Birmingham, UK.
Nithya KrishnanRenal Department, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK.
Rob HigginsSchool of Engineering, University of Warwick, Coventry, UK.
Natalia KhovanovaSchool of Engineering, University of Warwick, Coventry, UK.

Funding

EPSRC EP/K02504X/1EPSRC EP/W524645/1National Institute for Health Research HealthTech Research Centre for Accelerated Surgical careUHCW NHS Trust-Renal Transplant research funds
6 · The paper itself

Abstract

In HLA-incompatible transplantation, monitoring donor-specific antibodies (DSA) after transplantation informs clinical decision-making and the management of antibody-mediated rejection. Persistent post-transplant DSAs are associated with poorer graft survival compared to cases where DSAs resolve. Previously, four distinct early post-transplant DSA dynamic patterns were identified using a unique dataset with frequent DSA measurements and shown to be associated with AMR and graft outcomes. However, frequent testing is costly, and predicting outcomes using fewer DSA measurements could improve monitoring efficiency. A machine learning classifier based on dynamic time warping was used to identify early post-transplant DSA patterns from a reduced set of measurements. Individual days and day combinations within the first 50 post-transplant days were systematically evaluated. The combinations with the highest classification accuracy compared to using all available time points were selected as optimal. This study determined the minimum number of DSA screenings required to accurately classify early DSA dynamics. Measuring DSAs on Days 1, 10, and either 26 or 34 identified the four dynamic patterns with 93.7% accuracy. Including both Days 26 and 34 increased the accuracy to 96.9%. Testing beyond Day 34 did not yield further improvement in classification. Several monitoring regimens commonly used in clinical practice were evaluated, and the proposed approach outperformed all of them. This study identifies an efficient DSA monitoring strategy that can predict antibody behaviour early post-transplant, enabling timely intervention. It also addresses inconsistencies in current monitoring practices, offering evidence for standardised, data-driven protocols for more precise and efficient post-transplant care.

Indexed as

Graft RejectionHLA AntigensIsoantibodiesKidney TransplantationGraft SurvivalHumansMachine LearningTime FactorsHLA AntigensIsoantibodiesclassificationDSAHLAmachine learningpost‐transplant monitoringtransplantation

Identifiers

PMID41504493
PMCPMC12781962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.